The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-UK steps vaccinations as COVID surges, worst weeks still to come

Mon, 11th Jan 2021 07:42

(Adds more quotes)

By Michael Holden

LONDON, Jan 11 (Reuters) - Britain is facing the worst weeks
of the COVID-19 pandemic, its chief medical officer said on
Monday, with the health service facing a "dangerous time" as
deaths and cases hit record highs before the rollout of a mass
vaccination programme.

Deaths from the virus have now exceeded 81,000 in the United
Kingdom - the world's fifth-highest toll - with more than 3
million people testing positive. A new, more transmissible
variant of the disease is surging through the population, with
one in 20 people in parts of London now infected.

In a bid to get on top of the pandemic and to try to restore
some degree of normality by the spring, Britain is rushing out
its largest ever vaccination programme, with shots to be offered
to all those in its top four priority categories - about 15
million people - by the middle of next month.

But the government's chief medical adviser Chris Whitty
warned the situation would deteriorate in the meantime.

"The next few weeks are going to be the worst weeks of this
pandemic in terms of numbers into the NHS (National Health
Service)," he said.

"Anybody who is not shocked by the number of people in
hospital who are seriously ill at the moment and who are dying
over the course of this pandemic, I think, has not understood
this at all. This is an appalling situation," he told BBC TV.

"SIGNIFICANT CRISIS"

During the peak of the first outbreak in April, about 18,000
people were in hospital but now there are 30,000, Whitty said,
adding the health service was facing "a significant crisis".

"Everybody says that this is the most dangerous time we've
really had in terms of numbers into the NHS," he said.

On Friday, London's mayor said the British capital's
hospitals were in danger of being overwhelmed by COVID patients,
and ministers and health chiefs have pleaded with people to
respect lockdown measures and stay at home unless it was
essential to go out.

The government is pinning its hopes on a mass vaccination
programme to offer a way out of the pandemic by the spring.

Britain was the first country to approve vaccines developed
by Oxford-AstraZeneca and by Pfizer/BioNTech
, and on Friday approved Moderna's shot. It
is aiming to offer shots to 15 million people by the middle of
next month.

To reach that target, which will require delivering 2
million vaccines a week, the government is opening seven big
vaccination centres while additional doctors' surgeries,
hospitals and some pharmacies will also start delivering shots.

"The vaccinations are really beginning to ramp up, 200,000 a
day, we've done an incredible job this past week," Nadhim
Zahawi, the minister in charge of the vaccination programme,
told Sky News

Those in the four highest risk levels, including those over
70, the most clinically vulnerable and frontline health workers,
will be offered the vaccines by February 15, he said.

"We are now very close to the point, with the vaccinations,
where we are able to get on top of this, but it is not yet,"
Whitty said.

There have been calls for the government to take tougher
action against those who break the lockdown rules, but Zahawi
said ministers did not want to "go any tougher" although
existing measures might be more tightly enforced.

"These rules are not boundaries to be pushed against," he
said. "What we need is people to behave as if they've got the
virus and so that we can bring this virus under control whilst
we vaccinate."
(Additional reporting by Kate Holton, William Schomberg and
James Davey; writing by Michael Holden; editing by Estelle
Shirbon, Guy Faulconbridge and Angus MacSwan)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.